Baker Tilly Wealth Management’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,357
Closed -$222K 389
2024
Q1
$222K Sell
7,357
-435
-6% -$12.1K 0.04% 395
2023
Q4
$223K Sell
7,792
-424
-5% -$12.5K 0.04% 433
2023
Q3
$304K Sell
8,216
-3,198
-28% -$122K 0.05% 364
2023
Q2
$445K Sell
11,414
-116
-1% -$4.55K 0.05% 369
2023
Q1
$421K Sell
11,530
-3,875
-25% -$122K 0.05% 377
2022
Q4
$475K Buy
+15,405
New +$478K 0.06% 337

Other funds holding RTO

Baker Tilly Wealth Management's RTO Position: Q2 2024 in Review

Baker Tilly Wealth Management sold out of Rentokil (RTO) in Q2 2024, closing a stake of 7,357 shares — an estimated $222K sold.

Baker Tilly Wealth Management first reported a position in RTO in Q4 2022 and held it in 6 quarters. The position peaked at $475K in Q4 2022. 232 funds tracked by Wall St. Rank hold RTO as of Q2 2024.

  • Baker Tilly Wealth Management reported no remaining Rentokil position as of Q2 2024 after selling out during the quarter.
  • Baker Tilly Wealth Management sold 7,357 Rentokil shares in Q2 2024, an estimated $222K.
  • Baker Tilly Wealth Management first reported a position in Rentokil in Q4 2022 and held it in 6 quarters.
  • Baker Tilly Wealth Management's Rentokil position peaked at $475K in Q4 2022.
  • 232 funds tracked by Wall St. Rank held Rentokil as of Q2 2024.

Based on Baker Tilly Wealth Management's 13F filing for Q2 2024, filed 18 Jul 2024.